323
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

CD19 negative and dim precursor B-lineage acute lymphoblastic leukemias: real-world challenges in a targeted-immunotherapy era

, , , , &
Pages 3154-3160 | Received 05 Dec 2018, Accepted 19 May 2019, Published online: 11 Jun 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jhansi Rani Arumugam, Karthik Bommannan, Venkatraman Radhakrishnan, Tenali Gnana Sagar & Shirley Sundersingh. (2022) Immunophenotypic expression and immunomodulation in minimal residual disease analysis of pediatric B acute lymphoblastic leukemia by high sensitive flow cytometry. Leukemia & Lymphoma 63:3, pages 644-652.
Read now

Articles from other publishers (3)

Hari Menon, Pawan Kumar Singh, Bhausaheb Bagal, Tuphan Dolai, Ankita Jain & Antara Chaudhri. (2023) Minimal Residual Disease in the Management of B-Cell Acute Lymphoblastic Leukemia: A Systematic Review of Studies from Indian Settings. Indian Journal of Hematology and Blood Transfusion.
Crossref
Karthik Bommannan, Jhansi Rani Arumugam, Venkatraman Radhakrishnan, Jayachandran Perumal Kalaiyarasi, Parathan Karunakaran, Nikita Mehra, Tenali Gnana Sagar & Shirley Sundersingh. (2022) Relevance of flow cytometric categorization and end-of-induction measurable residual disease assessment in pediatric and adult T-lymphoblastic leukemia patients. Blood Research 57:3, pages 175-196.
Crossref
Wanying Zeng & Pumin Zhang. (2022) Resistance and recurrence of malignancies after CAR-T cell therapy. Experimental Cell Research 410:2, pages 112971.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.